NM_000292.3:c.2532G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000292.3(PHKA2):​c.2532G>A​(p.Leu844Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 1,182,524 control chromosomes in the GnomAD database, including 96 homozygotes. There are 5,145 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 7 hom., 270 hem., cov: 23)
Exomes 𝑓: 0.014 ( 89 hom. 4875 hem. )

Consequence

PHKA2
NM_000292.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.752

Publications

0 publications found
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXa1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • glycogen storage disease due to liver phosphorylase kinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant X-18907083-C-T is Benign according to our data. Variant chrX-18907083-C-T is described in ClinVar as Benign. ClinVar VariationId is 255774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.752 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00924 (1037/112242) while in subpopulation NFE AF = 0.0157 (836/53160). AF 95% confidence interval is 0.0148. There are 7 homozygotes in GnomAd4. There are 270 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA2NM_000292.3 linkc.2532G>A p.Leu844Leu synonymous_variant Exon 23 of 33 ENST00000379942.5 NP_000283.1 P46019

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA2ENST00000379942.5 linkc.2532G>A p.Leu844Leu synonymous_variant Exon 23 of 33 1 NM_000292.3 ENSP00000369274.4 P46019

Frequencies

GnomAD3 genomes
AF:
0.00924
AC:
1037
AN:
112186
Hom.:
7
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00204
Gnomad AMI
AF:
0.00586
Gnomad AMR
AF:
0.00508
Gnomad ASJ
AF:
0.00452
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00371
Gnomad FIN
AF:
0.00729
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.0157
Gnomad OTH
AF:
0.00797
GnomAD2 exomes
AF:
0.00939
AC:
1297
AN:
138133
AF XY:
0.00951
show subpopulations
Gnomad AFR exome
AF:
0.00201
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00452
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00972
Gnomad NFE exome
AF:
0.0163
Gnomad OTH exome
AF:
0.00978
GnomAD4 exome
AF:
0.0143
AC:
15344
AN:
1070282
Hom.:
89
Cov.:
30
AF XY:
0.0141
AC XY:
4875
AN XY:
345606
show subpopulations
African (AFR)
AF:
0.00217
AC:
56
AN:
25841
American (AMR)
AF:
0.00389
AC:
121
AN:
31093
Ashkenazi Jewish (ASJ)
AF:
0.00408
AC:
77
AN:
18874
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28884
South Asian (SAS)
AF:
0.00455
AC:
232
AN:
50972
European-Finnish (FIN)
AF:
0.0117
AC:
457
AN:
38939
Middle Eastern (MID)
AF:
0.00797
AC:
31
AN:
3888
European-Non Finnish (NFE)
AF:
0.0168
AC:
13868
AN:
826747
Other (OTH)
AF:
0.0111
AC:
502
AN:
45044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
510
1019
1529
2038
2548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00924
AC:
1037
AN:
112242
Hom.:
7
Cov.:
23
AF XY:
0.00785
AC XY:
270
AN XY:
34398
show subpopulations
African (AFR)
AF:
0.00204
AC:
63
AN:
30941
American (AMR)
AF:
0.00507
AC:
54
AN:
10642
Ashkenazi Jewish (ASJ)
AF:
0.00452
AC:
12
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3560
South Asian (SAS)
AF:
0.00372
AC:
10
AN:
2687
European-Finnish (FIN)
AF:
0.00729
AC:
45
AN:
6176
Middle Eastern (MID)
AF:
0.00465
AC:
1
AN:
215
European-Non Finnish (NFE)
AF:
0.0157
AC:
836
AN:
53160
Other (OTH)
AF:
0.00786
AC:
12
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
36
72
108
144
180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
97
Bravo
AF:
0.00887

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 18, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Glycogen storage disease IXa1 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
3.0
DANN
Benign
0.59
PhyloP100
0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61729452; hg19: chrX-18925201; API